The DEA recently released three rules regarding the remote prescribing of controlled substances. However, many telehealth ...

The U.S. Drug Enforcement Administration (DEA) recently announced new rules that will impact telemedicine practices, especially concerning ...

The DEA’s proposed 50/50 telehealth rule undermines the accessibility and effectiveness of psychiatric care by imposing unnecessary in-person visit requirements. Here's how.

The Drug Enforcement Administration ("DEA") announced three new regulations related to the prescription of controlled substances resulting from ...

In this proposed rulemaking’s approach, DEA distinguishes telemedicine providers by architecting three distinct categories subject to different levels of scrutiny. The first special registration ...

Congress first directed the DEA to create the special registration program in 2008. That law prevented providers from prescribing controlled substances through telehealth unless they received such ...

But the proposed rule, unveiled Wednesday by the U.S. Drug Enforcement Administration (DEA) and expected to be published on Friday, isn’t necessarily sitting well with telehealth advocates.

Healthcare executives are calling on the Trump Administration to nullify a DEA proposal to create a special registration for ...

via telemedicine. The move finally fulfills a mandate that DEA had largely ignored since Congress first issued it in 2008. But the new special registration system is merely a proposal ...

When the DEA issued its final rule in November on the fate of telehealth flexibilities created during the pandemic, it confirmed that DEA-registered practitioners can write prescriptions without ...